Navigation Links
SENOMYX ANNOUNCES INITIATION OF DEVELOPMENT ACTIVITIES FOR NEW BITTER BLOCKERS
Date:2/9/2009

ess would be beneficial for the many manufacturers who would like to improve the taste characteristics of their products."

This is the fourth time that Senomyx has initiated development activities to support regulatory filings for new flavor ingredients discovered by the Company. Senomyx is currently conducting development activities for a new sucrose enhancer, S6973, which enables the reduction of up to 50% of the sugar present in product prototypes. In addition, both S2383, an enhancer of the high-intensity sweetener sucralose, and the Company's savory flavor ingredients have received Generally Recognized As Safe (GRAS) regulatory status, which allows commercialization in the U.S. and other countries.

"Senomyx has gained important experience managing several flavor ingredients through the development phase and successful regulatory reviews," Snyder noted. "We believe this expertise will be helpful as we conduct our development activities with the new bitter blockers."

Senomyx has an extensive intellectual property portfolio of proprietary taste receptor technologies, including patents related to bitter taste. Each individual has 25 different types of taste receptors that are associated with the perception of bitter taste (T2Rs). The Company has been granted patent claims that cover the use of amino acids and nucleic acid sequences that encode many T2R receptor subunits, as well as variants of these bitter receptors, for identifying new bitter taste modulators.

About Senomyx, Inc. (www.senomyx.com)

Senomyx is a leading company using proprietary taste receptor technologies to discover and develop novel flavor ingredients in the savory, sweet, salt, bitter, and cooling areas. Senomyx has entered into product discovery, development, and commercialization collaborations with seven of the world's foremost food, beverage, a
'/>"/>

SOURCE Senomyx, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. SENOMYX, INC. fourth quarter AND FISCAL YEAR-END 2008 Earnings conference call scheduled for February 12, 2009
2. SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE 11TH ANNUAL NEEDHAM GROWTH STOCK CONFERENCE
3. SENOMYX AND FIRMENICH TO COLLABORATE ON COMMERCIALIZATION OF S2383, A NOVEL ENHANCER OF THE HIGH-INTENSITY SWEETENER SUCRALOSE
4. SENOMYX ANNOUNCES THIRD QUARTER 2008 FINANCIAL RESULTS
5. SENOMYX ANNOUNCES RECEIPT OF MILESTONE PAYMENT FROM THE COCA-COLA COMPANY
6. SENOMYX, INC. THIRD QUARTER 2008 EARNINGS CONFERENCE CALL SCHEDULED FOR NOVEMBER 6, 2008
7. SENOMYX CO-FOUNDER AND SCIENTIFIC ADVISORY BOARD MEMBER ROGER TSIEN, PH.D., AWARDED NOBEL PRIZE IN CHEMISTRY
8. SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE WACHOVIA CONSUMER GROWTH CONFERENCE
9. SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE CANACCORD ADAMS 28TH ANNUAL GLOBAL GROWTH CONFERENCE
10. SENOMYX ANNOUNCES INITIATION OF DEVELOPMENT ACTIVITIES FOR NEW SUCROSE ENHANCER
11. SENOMYX ANNOUNCES EXTENSION OF DISCOVERY AND DEVELOPMENT COLLABORATION WITH CADBURY PLC

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...hanghaiBiolaxyannouncedthe,ChineseStateFood&Dr...alnewdrugapplication(IND)foritsoralinsulinproject,...etes.ThisIND,approvalallowsBiolaxytoinitiateitsfir...haracteristicofhighbloodglucoseandpoor,metabolism....-and,macro-vasculardiseases,lossofvision,kidneyfai...
(Date:11/24/2009)...all/--Shireplc(LSE:SHP,NASDAQ: SHPGY ),theglobals...atithassubmittedaMAAtotheEuropeanMedicinesAgencyfo...herapyindevelopment,forthetreatmentofType1Gaucherd...lucerasealfathathasbeensubmitted,withprevious,subm...globalsupplyshortageofthecurrentlyapprovedandmarke...
(Date:11/24/2009)...s Service (CAS), the global expert on chemical inf...w the world,s leading producer of patent invention...patent office, the World Intellectual Property Org... Trademark Office (USPTO) for more than a decade, ...ceeded Japan for the first time on a monthly basis...
(Date:11/23/2009)...rbon layer in which the carbon atoms are arranged ...rbon nanotubes are rolled-up sheets of graphene, a...raphene boasts some very special characteristics ...al conductor, and reconciles such conflicting qual...raphene is impermeable to gases, which makes it in...
Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 3Polymer with honeycomb structure 2
...LC, a,subsidiary of MGT Capital Investments, Inc. ...opment of Computer-Aided Detection (CAD) and image...ction and diagnosis of,disease, today announced th... Food and Drug Administration ("SFDA") for its Med...his workstation via a Chinese dealer,network which...
...oval of the ATS 3f Valve, MINNEAPOLIS, April 10 ...nd marketer of state-of-the-art cardiac,surgery pr...th American,commercial implant of the ATS 3f(R) Ao...as received at the end of December, 2007. The firs... MSc, FRSC, Chairman,Division of Cardiac Surgery a...
...3.5 million, up 13 percent over fourth-quarte...CAMBRIDGE, Mass., April 10 Millennium,Pharmaceuti...quarter 2008,U.S. net sales of $83.5 million for i...der for the treatment of patients with relapsed mu...nt increase over fourth-quarter,2007 and a 42 perc...
Other Biology Technology:Medicsight Announces Chinese State Food and Drug Administration Approval for MedicRead Colon Workstation 2Medicsight Announces Chinese State Food and Drug Administration Approval for MedicRead Colon Workstation 3ATS Medical Announces First North American Commercial Implant of the ATS 3f Aortic Bioprosthesis 2ATS Medical Announces First North American Commercial Implant of the ATS 3f Aortic Bioprosthesis 3Millennium Announces VELCADE(R) (Bortezomib) for Injection First-Quarter 2008 U.S. Net Sales 2Millennium Announces VELCADE(R) (Bortezomib) for Injection First-Quarter 2008 U.S. Net Sales 3Millennium Announces VELCADE(R) (Bortezomib) for Injection First-Quarter 2008 U.S. Net Sales 4Millennium Announces VELCADE(R) (Bortezomib) for Injection First-Quarter 2008 U.S. Net Sales 5Millennium Announces VELCADE(R) (Bortezomib) for Injection First-Quarter 2008 U.S. Net Sales 6Millennium Announces VELCADE(R) (Bortezomib) for Injection First-Quarter 2008 U.S. Net Sales 7
(Date:11/23/2009)...ay matters to forest trees dealing with drought, a...m led by Professor Malcolm Campbell, University of... and colleagues in the department of cell and syst...lizing on their previous work to decode the genome...w poplar trees use their 45,000 genes to respond t...
(Date:11/23/2009)...ontrovertible evidence" that the volcanic super-er...00 years ago deforested much of central India, som...rt. , The volcano ejected an estimated 800 cubic...crater (now the world,s largest volcanic lake) tha...sh from the event has been found in India, the Ind...
(Date:11/23/2009)...ity of Alabama at Birmingham (UAB) researchers sho...cal conditions (co-morbidity) do not explain the d... compared to Caucasians who also have colon cancer... , a journal of the American Cancer Society. , T...idity are independent predictors of poor survival ...
Breaking Biology News(10 mins):Time of day matters to thirsty trees, U of T researcher discovers 2Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Ocean Spray Teams Up With the American Heart Associations Go Red For Women and Its Go Red BetterU Program 49202 1Ocean Spray Teams Up With the American Heart Associations Go Red For Women and Its Go Red BetterU Program 49202 2Ocean Spray Teams Up With the American Heart Associations Go Red For Women and Its Go Red BetterU Program 49202 3Cardium Receives Preliminary Notification of Inclusion in the Russell 3000 28R 29 Index and Russell Global 28R 29 Index 49199 1Cardium Receives Preliminary Notification of Inclusion in the Russell 3000 28R 29 Index and Russell Global 28R 29 Index 49199 2Cardium Receives Preliminary Notification of Inclusion in the Russell 3000 28R 29 Index and Russell Global 28R 29 Index 49199 3Cardium Receives Preliminary Notification of Inclusion in the Russell 3000 28R 29 Index and Russell Global 28R 29 Index 49199 4Cardium Receives Preliminary Notification of Inclusion in the Russell 3000 28R 29 Index and Russell Global 28R 29 Index 49199 5Tarrant County Hospital Takes Top Quality Award in Texas 49196 1Tarrant County Hospital Takes Top Quality Award in Texas 49196 2Tarrant County Hospital Takes Top Quality Award in Texas 49196 3
... A team of researchers, led by biologists at Dartm...rcury and arsenic in Lake Baiyangdian, the largest...h food and drinking water for the people who live ...ate locations in Lake Baiyangdian, all at varying ... coal emissions, agricultural runoff, and sewage d...
..., Is getting new knees on your list of New Year,s ...ware indicates that women wait longer to pursue kn...ng surgery until they can no longer stand the pain..., and quality of life, on hold indefinitely, accor...Professor in UD,s Department of Physical Therapy a...
... COLLEGE STATION, Jan. 9, 2008 If youre worried a...lthy as you get older, dont push aside bacon and e... provide a benefit., Researchers at Texas A&M Univ...ls can actually reduce muscle gain with exercising...fessor of health and kinesiology, and Simon Sheath...
Other Biology News:Dartmouth researchers alarmed by levels of mercury and arsenic in Chinese freshwater ecosystem 2Listen-up ladies: Don't postpone knee-replacement surgery 2Listen-up ladies: Don't postpone knee-replacement surgery 3Surprise -- cholesterol may actually pose benefits, study shows 2
... Antigen Design , Customer Peptide Synthesis , 2...bove 90% , 20 mg will return to customer for fut... Rabbits x 2 , Maintenance 102 days/each , ... injections x5 /each , Test bleed (app. 5 ml) ...
...t Contains the following: , Coated Capture Antib..., Wash/Sample Diluent: 300 mL of 2X concentrate ,...yophilized peptide , Lyophilized Standard Diluen...ncentrate , Secondary Antibody-HRP: 30 microL of...
THP-1 Cell Slide from ProSci, Inc
Acrylamide/Bis 19:1 40% (w/v) solution from Ambion
Biology Products: